首页> 外文OA文献 >Outcome and risk factor of immune‐related adverse events and pneumonitis in patients with advanced or postoperative recurrent non‐small cell lung cancer treated with immune checkpoint inhibitors

【2h】

Outcome and risk factor of immune‐related adverse events and pneumonitis in patients with advanced or postoperative recurrent non‐small cell lung cancer treated with immune checkpoint inhibitors

机译：用免疫检查点抑制剂治疗的晚期或术后复发性非小细胞肺癌患者免疫相关不良事件和肺炎的结果和危险因素

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Taisuke Isono; Naho Kagiyama; Kenji Takano; Chiaki Hosoda; Takashi Nishida; Eriko Kawate; Yoichi Kobayashi; Takashi Ishiguro; Youtaro Takaku; Kazuyoshi Kurashima; Tsutomu Yanagisawa; Noboru Takayanagi;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Outcome and risk factor of immune‐related adverse events and pneumonitis in patients with advanced or postoperative recurrent non‐small cell lung cancer treated with immune checkpoint inhibitors [J] . Taisuke Isono, Naho Kagiyama, Kenji Takano, Thoracic cancer. . 2021,第2期

机译：用免疫检查点抑制剂治疗的晚期或术后复发性非小细胞肺癌患者免疫相关不良事件和肺炎的结果和危险因素
2. Adverse impact of bone metastases on clinical outcomes of patients with advanced non‐small cell lung cancer treated with immune checkpoint inhibitors [J] . Xing Li, Lei Wang, Shanhao Chen, Thoracic cancer. . 2020,第10期

机译：骨转移对患有免疫检查点抑制剂治疗的晚期非小细胞肺癌临床结果的不良影响
3. Discontinuation due to immune‐related adverse events is a possible predictive factor for immune checkpoint inhibitors in patients with non‐small cell lung cancer [J] . Kazutoshi Komiya, Tomomi Nakamura, Tomonori Abe, Thoracic cancer. . 2019,第9期

机译：由于免疫相关不良事件导致的停药是非小细胞肺癌患者免疫检查点抑制剂的可能预测因素
4. ENGINEERING AND PRE-CLINICAL EVALUATION OF A HUMAN ENZYME IMMUNE CHECKPOINT INHIBITOR FOR CANCER THERAPY [C] . Everett Stone, John Blazek, Christos Karamitros, Enzyme Engineering Conference . 2018

机译：癌症治疗人酶免疫检查点抑制剂的工程与临床评价
5. Immune-Related Adverse Events in Cancer Patients Being Treated with Immune Checkpoint Inhibitors [D] . Byrne, Margaret M. 2021

机译：用免疫检查点抑制剂治疗癌症患者免疫相关不良事件
6. Outcome and risk factor of immune‐related adverse events and pneumonitis in patients with advanced or postoperative recurrent non‐small cell lung cancer treated with immune checkpoint inhibitors [O] . Taisuke Isono, Naho Kagiyama, Kenji Takano, 2021

机译：用免疫检查点抑制剂治疗的晚期或术后复发性非小细胞肺癌患者免疫相关不良事件和肺炎的结果和危险因素
7. Immune-related adverse events (irAEs) and outcome in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients (pts) treated by immune-checkpoints inhibitors (ICI) [O] . N. Baste Rotllan, A. Auperin, M. Iacob, 2019

机译：免疫相关/转移性（R / M）头和颈部鳞状细胞癌（HNSCC）患者（PTS）的免疫相关不良事件（IRAES）和结果进行免疫检查点抑制剂（ICI）

Outcome and risk factor of immune‐related adverse events and pneumonitis in patients with advanced or postoperative recurrent non‐small cell lung cancer treated with immune checkpoint inhibitors

著录项

引文网络

相似文献

相关主题

期刊订阅